Search
4D Molecular Therapeutics Inc
FDMTAdd to Watchlist
10.180USD
+0.110+1.09%
Close 07-31 16:00（ET）Quotes delayed by 15 min
532.17MMarket Cap
LossP/E TTM
FDMT Financials
See 4D Molecular Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
4D Molecular Therapeutics Inc Earnings Date
Latest Release
May 7, 2026
EPS / Forecast
-1.01/-0.93
Revenue / Forecast
3.05M/5.17M
Period
FY2025 Earnings
Revenue(YoY)
85.21M
230194.59%
EPS(YoY)
-2.42
18.90%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What is the total revenue of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its total revenue reached 85.21M, with a year-on-year change of 37.00K.
What are the current assets of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its current assets were 413.13M, with a year-on-year change of -5.01.
What are the total assets of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its total assets of 4D Molecular Therapeutics Inc were 566.71M, with a year-on-year change of 1.13.
What are the total liabilities of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its total liabilities of 4D Molecular Therapeutics Inc were 61.05M, with a year-on-year change of 22.64.
What is the total equity of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its total equity of 4D Molecular Therapeutics Inc was 505.66M, with a year-on-year change of -0.97.
What is the net operating income of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its net operating income of 4D Molecular Therapeutics Inc was -159.55M, with a year-on-year change of 15.06.
What is the net investment of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its net investment of 4D Molecular Therapeutics Inc was -92.97M, with a year-on-year change of 69.26.
What is the net financing of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its net financing of 4D Molecular Therapeutics Inc was 112.96M, with a year-on-year change of -66.51.
What is the Earnings Per Share (EPS) of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.42, with a year-on-year change of 18.90.
What is the net income of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its net income was -140.11M, with a year-on-year change of 12.90.
What is the net margin of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its net profit margin was -164.43, with a year-on-year change of 99.96.
What is the Return on Equity (ROE) of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -27.57, with a year-on-year change of 29.86.
What is the Return on Assets (ROA) of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -24.86, with a year-on-year change of 30.43.
What is the operating profit of 4D Molecular Therapeutics Inc?
According to 4D Molecular Therapeutics Inc's FY2025 earnings report, its operating profit was -159.55M, with a year-on-year change of 15.06.